Racial Differences in Productivity Loss Attributable to Rheumatoid Arthritis Among Patients Taking Disease-Modifying Antirheumatic Drugs (DMARDs)

被引：0
|
作者：
Bozzi, Laura M. [1 ]
Gaitonde, Priyanka [1 ]
Shaya, Fadia [1 ]
Tom, Sarah E. [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1062
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [31] EBM analysis: Classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis
    Niehues, T.
    Winterhalter, S.
    Zierhut, M.
    Michels, H.
    Becker, M. D.
    Heiligenhaus, A.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (06) : 520 - 525
  • [32] Disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: Medical education
    Top, Cihan
    Terekeci, Hakan
    [J]. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2008, 28 (03): : 387 - 398
  • [33] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS - CURRENT CONCEPTS
    EMERY, P
    LUQMANI, R
    GORDON, C
    [J]. BRITISH JOURNAL OF CLINICAL PRACTICE, 1994, 48 (02): : 82 - 86
  • [34] Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
    Solomon, Daniel H.
    Tonner, Chris
    Lu, Bing
    Kim, Seoyoung C.
    Ayanian, John Z.
    Brookhart, M. Alan
    Katz, Jeffrey N.
    Yelin, Ed
    [J]. ARTHRITIS CARE & RESEARCH, 2014, 66 (08) : 1152 - 1158
  • [35] Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritis
    Galiuto, Leonarda
    Patrono, Carlo
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (17) : 1615 - 1616
  • [36] Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis
    Costa, Neide Tomimura
    Veiga Iriyoda, Tatiana Mayumi
    Alfieri, Daniela Frizon
    Colado Simao, Andrea Name
    Dichi, Isaias
    [J]. INFLAMMOPHARMACOLOGY, 2018, 26 (05) : 1151 - 1164
  • [37] Causes of poor adherence to disease-modifying antirheumatic drugs in Mexican patients with rheumatoid arthritis
    Morales-Romero, J
    González-López, L
    Rodríguez-Arreola, BE
    Celis, A
    Gémez-Nava, JI
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 406 - 406
  • [38] Use of Nonbiologic Disease-Modifying Antirheumatic Drugs and Risk of Infection in Patients With Rheumatoid Arthritis
    Dejaco, Christian
    Duftner, Christina
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (04): : 217 - +
  • [39] Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs
    Kim, Seoyoung C.
    Solomon, Daniel H.
    Liu, Jun
    Franklin, Jessica M.
    Glynn, Robert J.
    Schneeweiss, Sebastian
    [J]. AMERICAN JOURNAL OF MEDICINE, 2015, 128 (05): : 539.e7 - 539.e17
  • [40] Secondary prevention of atherosclerosis in patients with rheumatoid arthritis: focus on disease-modifying antirheumatic drugs
    Bublikov, D.
    Babushkin, I. E.
    [J]. CARDIOVASCULAR RESEARCH, 2018, 114 : S134 - S134
12345